Nexeon Medsystems Inc (OTCMKTS:NXNN) – Research analysts at Taglich Brothers issued their FY2017 EPS estimates for shares of Nexeon Medsystems in a research note issued to investors on Tuesday. Taglich Brothers analyst H. Halpern anticipates that the company will post earnings per share of ($0.14) for the year. Taglich Brothers has a “Speculative Buy” rating on the stock. Taglich Brothers also issued estimates for Nexeon Medsystems’ Q4 2017 earnings at ($0.03) EPS, Q1 2018 earnings at ($0.03) EPS, Q2 2018 earnings at ($0.03) EPS, Q3 2018 earnings at ($0.03) EPS, Q4 2018 earnings at ($0.04) EPS and FY2018 earnings at ($0.13) EPS.
WARNING: This article was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://stocknewstimes.com/2018/01/12/nexeon-medsystems-inc-nxnn-forecasted-to-earn-fy2017-earnings-of-0-14-per-share.html.
About Nexeon Medsystems
Nexeon MedSystems, Inc is a bioelectronics company developing active medical devices for the treatment of cardiovascular disease. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology.
Receive News & Ratings for Nexeon Medsystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexeon Medsystems and related companies with MarketBeat.com's FREE daily email newsletter.